{"id":"https://openalex.org/W2885648053","doi":"https://doi.org/10.1212/wnl.90.15_supplement.p1.361","title":"Demonstration of Equivalence of Generic Glatiramer Acetate (GA) Produced by Mylan to Copaxone\u00ae (P1.361)","display_name":"Demonstration of Equivalence of Generic Glatiramer Acetate (GA) Produced by Mylan to Copaxone\u00ae (P1.361)","publication_year":2018,"publication_date":"2018-04-10","ids":{"openalex":"https://openalex.org/W2885648053","doi":"https://doi.org/10.1212/wnl.90.15_supplement.p1.361","mag":"2885648053"},"language":"en","primary_location":{"id":"doi:10.1212/wnl.90.15_supplement.p1.361","doi":"https://doi.org/10.1212/wnl.90.15_supplement.p1.361","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.90.15_supplement.p1.361","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5043874873","display_name":"Peter E. Lipsky","orcid":"https://orcid.org/0000-0002-9287-1676","observed_orcids":["https://orcid.org/0000-0002-9287-1676"]},"institutions":[{"id":"https://openalex.org/I4210110460","display_name":"Ampel BioSolutions (United States)","ror":"https://ror.org/01z71je29","country_code":"US","type":"company","lineage":["https://openalex.org/I4210110460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peter Lipsky","raw_affiliation_strings":["AMPEL BioSolutions Charlottesville VA United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AMPEL BioSolutions Charlottesville VA United States","institution_ids":["https://openalex.org/I4210110460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019513359","display_name":"Patrick T. Vallano","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210159288","display_name":"Mylan (United States)","ror":"https://ror.org/04nsw4151","country_code":"US","type":"company","lineage":["https://openalex.org/I4210159288","https://openalex.org/I4387153459"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Patrick Vallano","raw_affiliation_strings":["Mylan Laboratories Morgantown WV United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mylan Laboratories Morgantown WV United States","institution_ids":["https://openalex.org/I4210159288"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109905487","display_name":"Jeffrey Bingham Smith","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210159288","display_name":"Mylan (United States)","ror":"https://ror.org/04nsw4151","country_code":"US","type":"company","lineage":["https://openalex.org/I4210159288","https://openalex.org/I4387153459"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey Smith","raw_affiliation_strings":["Mylan Laboratories Morgantown WV United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mylan Laboratories Morgantown WV United States","institution_ids":["https://openalex.org/I4210159288"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026248462","display_name":"Viswanath Bandaru","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210159288","display_name":"Mylan (United States)","ror":"https://ror.org/04nsw4151","country_code":"US","type":"company","lineage":["https://openalex.org/I4210159288","https://openalex.org/I4387153459"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Viswanath Bandaru","raw_affiliation_strings":["Mylan Laboratories Morgantown WV United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mylan Laboratories Morgantown WV United States","institution_ids":["https://openalex.org/I4210159288"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050792625","display_name":"Yunfu Sun","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210159288","display_name":"Mylan (United States)","ror":"https://ror.org/04nsw4151","country_code":"US","type":"company","lineage":["https://openalex.org/I4210159288","https://openalex.org/I4387153459"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yunfu Sun","raw_affiliation_strings":["Mylan Laboratories Morgantown WV United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mylan Laboratories Morgantown WV United States","institution_ids":["https://openalex.org/I4210159288"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060070449","display_name":"Ross Wallingford","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210159288","display_name":"Mylan (United States)","ror":"https://ror.org/04nsw4151","country_code":"US","type":"company","lineage":["https://openalex.org/I4210159288","https://openalex.org/I4387153459"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ross Wallingford","raw_affiliation_strings":["Mylan Laboratories Morgantown WV United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mylan Laboratories Morgantown WV United States","institution_ids":["https://openalex.org/I4210159288"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Joseph Duncan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210159288","display_name":"Mylan (United States)","ror":"https://ror.org/04nsw4151","country_code":"US","type":"company","lineage":["https://openalex.org/I4210159288","https://openalex.org/I4387153459"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph Duncan","raw_affiliation_strings":["Mylan Laboratories Morgantown WV United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mylan Laboratories Morgantown WV United States","institution_ids":["https://openalex.org/I4210159288"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006499993","display_name":"Joshua Lewis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210159288","display_name":"Mylan (United States)","ror":"https://ror.org/04nsw4151","country_code":"US","type":"company","lineage":["https://openalex.org/I4210159288","https://openalex.org/I4387153459"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joshua Lewis","raw_affiliation_strings":["Mylan Laboratories Morgantown WV United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mylan Laboratories Morgantown WV United States","institution_ids":["https://openalex.org/I4210159288"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070867686","display_name":"Jason Southall","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210159288","display_name":"Mylan (United States)","ror":"https://ror.org/04nsw4151","country_code":"US","type":"company","lineage":["https://openalex.org/I4210159288","https://openalex.org/I4387153459"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jason Southall","raw_affiliation_strings":["Mylan Laboratories Morgantown WV United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mylan Laboratories Morgantown WV United States","institution_ids":["https://openalex.org/I4210159288"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5102742453","display_name":"Azeem Ansari","orcid":"https://orcid.org/0000-0002-9847-5404","observed_orcids":["https://orcid.org/0000-0002-9847-5404"]},"institutions":[{"id":"https://openalex.org/I4210159288","display_name":"Mylan (United States)","ror":"https://ror.org/04nsw4151","country_code":"US","type":"company","lineage":["https://openalex.org/I4210159288","https://openalex.org/I4387153459"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Azeem Ansari","raw_affiliation_strings":["Mylan Laboratories Morgantown WV United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mylan Laboratories Morgantown WV United States","institution_ids":["https://openalex.org/I4210159288"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.11048695,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"90","issue":"15_supplement","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.7099999785423279,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.7099999785423279,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.17759999632835388,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.03500000014901161,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glatiramer-acetate","display_name":"glatiramer acetate","score":0.9900000095367432},{"id":"https://openalex.org/keywords/generic-drug-equivalence","display_name":"generic drug equivalence","score":0.6959999799728394},{"id":"https://openalex.org/keywords/mylan","display_name":"Mylan","score":0.7459999918937683},{"id":"https://openalex.org/keywords/drug-substitution","display_name":"drug substitution","score":0.33500000834465027},{"id":"https://openalex.org/keywords/multiple-sclerosis","display_name":"multiple sclerosis","score":0.5490000247955322},{"id":"https://openalex.org/keywords/bioequivalence","display_name":"bioequivalence","score":0.6370000243186951}],"concepts":[{"id":"https://openalex.org/C2778577042","wikidata":"https://www.wikidata.org/wiki/Q418274","display_name":"Glatiramer acetate","level":3,"score":0.8449668884277344},{"id":"https://openalex.org/C2780069185","wikidata":"https://www.wikidata.org/wiki/Q7977945","display_name":"Equivalence (formal languages)","level":2,"score":0.6486367583274841},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4810795485973358},{"id":"https://openalex.org/C556039675","wikidata":"https://www.wikidata.org/wiki/Q771035","display_name":"Traditional medicine","level":1,"score":0.33097994327545166},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.315530389547348},{"id":"https://openalex.org/C202444582","wikidata":"https://www.wikidata.org/wiki/Q837863","display_name":"Pure mathematics","level":1,"score":0.19553500413894653},{"id":"https://openalex.org/C2780640218","wikidata":"https://www.wikidata.org/wiki/Q8277","display_name":"Multiple sclerosis","level":2,"score":0.1535085141658783},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.11655950546264648}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1212/wnl.90.15_supplement.p1.361","doi":"https://doi.org/10.1212/wnl.90.15_supplement.p1.361","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.90.15_supplement.p1.361","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4200361830","https://openalex.org/W1947037341","https://openalex.org/W2115586444","https://openalex.org/W2808754952","https://openalex.org/W2593047737","https://openalex.org/W2991473670","https://openalex.org/W2954865583","https://openalex.org/W6922251676","https://openalex.org/W2770041800","https://openalex.org/W2808605120"],"abstract_inverted_index":{"Objective:":[0],"To":[1],"demonstrate":[2],"equivalence":[3,206,225],"of":[4,11,47,50,78,88,130,145,156,163,201,207,221,226,240],"Mylan\u2019s":[5],"glatiramer":[6],"acetate":[7],"(MGA)":[8],"to":[9,71,193,213,232],"that":[10,77,254,283],"reference":[12],"product":[13],"Copaxone":[14],"\u00ae":[15],"(COP),":[16],"using":[17,109,168,182,258],"the":[18,30,45,63,143,164,183,259,269,286],"4":[19],"criteria":[20,288],"for":[21,44,94,119,272,289,299,325,378,400,421,442,463,515,558,579],"active":[22],"pharmaceutical":[23],"ingredient":[24],"(API)":[25],"sameness":[26,241],"as":[27,80,188,263,359,497,549],"established":[28],"by":[29,62],"US":[31],"Food":[32],"and":[33,58,90,101,113,121,137,142,190,198,209,216,228,234,236,277],"Drug":[34],"Administration":[35],"(FDA).":[36],"Background:":[37],"GA":[38,55],"is":[39,180,256,265],"an":[40,154,360,498,550],"immune":[41],"modulator":[42],"indicated":[43],"treatment":[46],"relapsing":[48],"forms":[49],"multiple":[51,202],"sclerosis":[52],"(MS).":[53],"Two":[54],"products,":[56],"MGA":[57,73,89,179,208,227,255,284],"COP,":[59,79,264],"are":[60],"approved":[61],"FDA.":[64],"Design/Methods:":[65],"The":[66],"fundamental":[67,185,261],"reaction":[68,186],"scheme":[69,187],"used":[70],"produce":[72],"was":[74,166,191,357,495,547],"compared":[75],"with":[76,153,211,230,311,337,390,412,433,454,475,527,570,591],"determined":[81],"from":[82,506],"publically":[83],"available":[84],"literature.":[85],"Comparative":[86],"analyses":[87],"COP":[91,189,210,229],"were":[92,107,151],"performed":[93],"physicochemical":[95,196],"properties,":[96],"including":[97,123],"amino":[98,132,139],"acid":[99,140],"composition":[100],"molecular":[102],"weight":[103],"distributions.":[104],"Spectroscopic":[105],"fingerprints":[106],"obtained":[108],"Fourier":[110],"transform":[111],"infrared":[112],"circular":[114],"dichroism":[115],"spectroscopy.":[116],"Structural":[117],"signatures":[118,204,271],"polymerization":[120],"depolymerization,":[122,215],"total":[124],"diethylamine":[125],"(DEA)":[126],"content,":[127],"relative":[128],"proportions":[129],"DEA-adducted":[131],"acids,":[133],"peptide":[134],"mapping,":[135],"N-":[136],"C-terminal":[138],"sequences,":[141],"proportion":[144],"DEA":[146],"capped":[147],"versus":[148],"uncapped":[149],"C-termini,":[150],"probed":[152],"array":[155],"highly":[157],"sensitive":[158],"analytical":[159],"methods.":[160],"Biological":[161],"activity":[162],"products":[165],"assessed":[167],"murine":[169],"experimental":[170],"allergic":[171],"encephalomyelitis":[172],"(EAE),":[173],"a":[174,243,303,329,382,404,425,446,467,519,562,583],"rigorous":[175],"MS":[176,246],"model.":[177,247],"Results:":[178],"produced":[181,257],"same":[184,260,270],"shown":[192],"have":[194],"equivalent":[195,279],"properties":[197],"composition.":[199],"Analyses":[200],"structural":[203],"demonstrated":[205,224,253],"regard":[212],"polymerization,":[214],"propagational":[217],"shift.":[218],"A":[219,249],"series":[220],"EAE":[222],"studies":[223],"respect":[231],"toxicity":[233],"activity,":[235,281],"provided":[237],"confirmatory":[238],"evidence":[239],"in":[242,347,353,369,485,491,537,543],"validated,":[244],"in-vivo":[245],"Conclusions:":[248],"rigorous,":[250],"multipronged":[251],"program":[252],"chemistry":[262],"physicochemically":[266],"equivalent,":[267],"has":[268,278,295,321,374,396,417,438,459,502,511,554,575],"key":[273],"manufacturing":[274],"processing":[275],"steps,":[276],"biological":[280],"concluding":[282],"meets":[285],"FDA":[287],"API":[290],"sameness.":[291],"Disclosure:":[292],"Dr.":[293,319,340,355,362,372,394,415,436,457,478,493,500,509,530,545,552,573],"Lipsky":[294],"received":[296,322,375,397,418,439,460,503,512,555,576],"personal":[297,323,376,398,419,440,461,513,556,577],"compensation":[298,324,377,399,420,441,462,514,557,578],"consulting,":[300,326,379,401,422,443,464,516,559,580],"serving":[301,327,380,402,423,444,465,517,560,581],"on":[302,328,381,403,424,445,466,518,561,582],"scientific":[304,330,383,405,426,447,468,520,563,584],"advisory":[305,331,384,406,427,448,469,521,564,585],"board,":[306,332,385,407,428,449,470,522,565,586],"speaking,":[307,333,386,408,429,450,471,523,566,587],"or":[308,334,387,409,430,451,472,524,567,588],"other":[309,335,388,410,431,452,473,525,568,589],"activities":[310,336,389,411,432,453,474,526,569,590],"Janssen,":[312],"EMD":[313],"Serono,":[314],"Horizon,":[315],"Sanofi,":[316],"Roche,":[317],"WSG&R.":[318],"Vallano":[320,341,356,363],"Mylan":[338,348,370,392,413,434,455,476,486,507,528,538,571,592],"Laboratories.":[339,371,414,435,456,477,508,529,572,593],"holds":[342,364,480,532],"stock":[343,345,365,367,481,483,533,535],"and/or":[344,366,482,534],"options":[346,368,484,536],"Laboratories,":[349,487,539],"which":[350,354,488,492,540,544],"sponsored":[351,489,541],"research":[352,490,504,542],"involved":[358,496,548],"investigator.":[361,499,551],"Smith":[373],"Employee:":[391],"Inc.":[393],"Bandaru":[395],"Sun":[416],"Wallingford":[437],"Duncan":[458,479,494,501],"support":[505],"Lewis":[510,531,546],"Southall":[553],"Ansari":[574]},"counts_by_year":[],"updated_date":"2026-10-26T11:51:55.731654","created_date":"2018-08-22T00:00:00"}